SummaryThe UK screening committee says routine prostate cancer screening may cause more harm than good, recommending it only for men aged 45–61 with BRCA mutations. Evidence shows high overdiagnosis and unnecessary treatment. Reactions are split, prompting a three-month consultation before final guidance, with critics calling it a missed opportunity for many men.